Heart attack drug could limit damage, study hopes
NCT ID NCT07293832
First seen Jan 06, 2026 · Last updated May 03, 2026 · Updated 19 times
Summary
This study is testing whether giving a quick-acting beta-blocker (landiolol) early during a heart attack can reduce the amount of heart muscle that dies. Researchers will compare this to standard oral beta-blocker treatment in 100 adults with a severe type of heart attack called STEMI. The goal is to see if the fast-acting drug leads to better heart function and less scarring.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STEMI are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hippokration General Hospital of Thessaloniki
RECRUITINGThessaloniki, Thessaloniki, 546 42, Greece
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.